WPI 2345 (Lacosamide 200 mg)
Pill imprint WPI 2345 has been identified as Lacosamide 200 mg.
Lacosamide is used in the treatment of seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
More about lacosamide
- Lacosamide solution
- Lacosamide tablets
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
- Other brands: Vimpat
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.